Carole A. Sable
Hoofd Techniek/Wetenschap/O&O bij VITAE PHARMACEUTICALS INC
Actieve functies van Carole A. Sable
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VITAE PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 06-06-2016 | - |
| BASILEA PHARMACEUTICA AG | Directeur/Bestuurslid | 27-04-2023 | - |
Loopbaan van Carole A. Sable
Eerdere bekende functies van Carole A. Sable
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SCYNEXIS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 20-02-2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2010 | 01-01-2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-1995 | 01-01-2007 |
| University of Virginia | Corporate Officer/Principal | 01-01-1993 | 01-01-1995 |
| REVOLUTION MEDICINES, INC. | Hoofd Techniek/Wetenschap/O&O | 05-03-2015 | - |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Carole A. Sable
| Sidney Kimmel Medical College | Doctorate Degree |
| Thomas Jefferson University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Frankrijk | 2 |
| Zwitserland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
- Beurs
- Insiders
- Carole A. Sable
- Ervaring
